Objective To determine the 30-day readmission rate after seizure-related discharge in a nationally representative sample, as well as patient, clinical, and hospital characteristics associated with readmission.
As health care costs continue to rise, increasing attention has focused on the question of how to provide high value patient care.
1 Current health care legislation contains payment incentives aimed at improving quality of care and lowering costs, and readmissions have emerged as a cornerstone indicator of quality and value in inpatient care. 2 Hospital readmissions in 2011 were estimated to have cost $41.3 billion in the United States. 3 In order to achieve mandates for reduced readmissions, it is necessary to understand the drivers of readmission.
Previous studies have examined the frequency of readmission in a subset of the population with epilepsy (members of a particular health plan) or in specific patient populations admitted with seizure such as postsurgical patients, and found readmission rates from less than 5% to 29%. [4] [5] [6] [7] [8] This variability likely reflects the effects of differences in patient and hospital characteristics and limits our ability to rely on the current literature for benchmark readmission data. Therefore, on a national level, little is known about the risk factors for readmission of seizure patients or the burden of readmission in this population. We attempted to address this knowledge gap by examining readmissions after admission for seizure in a nationally representative sample. The primary objective of this study was to determine the national 30-day nonelective readmission rate in patients emergently hospitalized for seizure. Secondary objectives were to identify patient and hospitalization characteristics associated with nonelective readmission at 30 and 90 days.
Methods

Data
We utilized data from the US Healthcare Cost and Utilization Project's 2014 Nationwide Readmissions Database (NRD), the largest all-payer inpatient health care national readmissions database, which is made available by the Agency for Healthcare Research and Quality. This database contains deidentified information regarding patient demographics, measures of comorbidity, diagnoses, procedures, admission and disposition details, payer information, and hospital characteristics. Our study examined seizure and epilepsy admissions from approximately 35 million distinct hospitalizations in 2014.
Study design and population
We performed a retrospective cohort study of emergently hospitalized adults with a primary discharge diagnosis of seizure or epilepsy, as defined by the ICD-9 diagnosis codes for convulsion (ICD-9 780.3) or epilepsy (ICD-9 345.x). 9, 10 If an individual had more than one potential qualifying hospitalization in 2014 (any hospitalization with a primary discharge diagnosis of seizure or epilepsy), we randomly chose one of these hospitalizations to serve as the index encounter. Admissions were excluded if the patient was younger than 18 years or died during the index hospitalization, if the hospitalization was designed as elective, if the patient left against medical advice, or if the hospitalization occurred less than 30 days (or 90 days) prior to the end of the year (due to insufficient follow-up).
Patient and clinical characteristics
We extracted data on patient characteristics including age, sex, primary payment source (Medicare, Medicaid, private insurance, uninsured/self-pay, no charge, other), and median household income (categorized in the NRD as quartiles of the median income in the patients' postal code). Age was also categorized as 18-39 years, 40-49 years, 50-59 years, 60-69 years, 70-79 years, or 80+ years. The NRD does not include data on race/ethnicity. NRD software allows researchers to identify 29 preexisting chronic medical conditions and to calculate an Elixhauser comorbidity score. The Elixhauser comorbidity score was categorized as 0-1, 2, 3, and 4+ comorbid conditions. Hospital characteristics available in the NRD include teaching status, hospital bed size, and hospital control (government, nonprofit, for-profit). The NRD does not allow researchers to perform hierarchical analyses at the hospital level, which is necessary to examine the relationship between provider capacity or volume and outcomes.
Outcomes
The primary outcome was nonelective readmission within 30 days. We considered only the first nonelective readmission within the observation window. A secondary outcome was nonelective readmission within 90 days. If an individual had more than one nonelective readmission during the 30-or 90-day window, we considered only the first readmission in our analysis. We also examined readmission rates associated with complications of seizure as defined by ICD codes: status epilepticus, altered mental status/delirium, and mechanical ventilation/endotracheal intubation (appendix 1). Finally, adverse events were identified using ICD-9 codes E8700-E8799 (for adverse effects of medical care) and E9300-E9499 (for adverse effects of medical drugs).
In secondary analyses, we examined readmission rates in subgroups of patients with the following additional diagnoses present at the index admission: brain tumor, intracerebral hemorrhage, subarachnoid hemorrhage, traumatic brain injury, intoxication, and CNS infection (see appendix 1 for related ICD-9 codes, as well as references for prior validation studies).
Glossary AOR = adjusted odds ratio; CI = confidence interval; ICD-9 = International Classification of Diseases-9; NRD = Nationwide Readmissions Database; OR = odds ratio. 
Statistical analysis
Demographic characteristics were compared using χ 2 tests for categorical variables. To examine patient, hospital, and clinical characteristics associated with readmission, we built multivariable logistic regression models to estimate the odds of readmission for each characteristic. Model variables were initially selected a priori based on clinical knowledge and review of existing literature and variable availability in NRD data. All estimates were generated using survey-weighted methods to account for the complex survey design of the NRD and generate national estimates for all variables. In particular, we used the full cohort to maintain all strata and yield proper variance estimates as intended by HCUP. The statistical analyses for our study were performed using SAS software, version 9.4 (SAS Institute, Inc., Cary, NC).
Standard protocol approvals, registrations, and patient consents This study was approved by the University of Pennsylvania's Institutional Review Board.
Data availability statement
The US Healthcare Cost and Utilization Project's 2014 Nationwide Readmissions Database is a publicly available dataset.
Results
Demographics
We identified a total of 139,800 hospitalizations that met all inclusion criteria for 30-day readmission. Of these, 15,094 patients (10.8%) were readmitted within 30 days. Table 1 displays patient, clinical, and hospitalization characteristics of the study sample, stratified by readmission status. A total of 79.2% of readmitted patients had public insurance, either through the Medicare or Medicaid programs, compared to 68.9% of nonreadmitted patients. Male and female patients were distributed similarly by readmission status. Comorbid disease burden was greater among readmitted patients-62.2% of persons who were readmitted had 4 or more chronic medical conditions, compared to 45.9% of persons not readmitted. Of the 29 chronic conditions that are able to be identified in the NRD, all but 2 (drug abuse, chronic blood loss anemia) were more frequent among readmitted patients. Readmitted patients more frequently utilized postacute care (either home health care or discharge to a facility), 41.1% vs 29.0% among nonreadmitted persons, and more frequently had an index hospitalization lasting a week or more. Finally, an adverse event was recorded more often during the index admission of readmitted patients (10.1% vs 7.3% in nonreadmitted). The distribution of median zip code income and hospital characteristic categories did not significantly vary by readmission status. The most common reason for readmission was epilepsy or convulsion, followed by sepsis (17% and 7% of readmissions, respectively).
Factors associated with 30-day readmission
Multivariate logistic regression models that included patient, clinical, and index hospitalization characteristics produced adjusted odds ratios (AORs) that demonstrated that several study variables were associated with readmission. As shown in Home with home health care 3,612 (14.6) 9,564 (10.5)
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Discussion
In this study, we describe a 30-day readmission rate of 10.8% in a nationally representative sample of hospital admissions. Prior studies have been in a variety of cohorts with differing primary outcomes (both seizure and epilepsy); they have additionally only examined subsets of the population such as members of a particular health plan or specific patient populations such as postsurgical patients.
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The 30-day readmission metric is important as it is increasingly being used to assess hospital performance. Currently, the Medicare program (which is the payor for a substantial proportion of hospitalized persons with seizure in this national dataset) is no longer providing payment for inpatient care delivered within 30 days after an index admission for heart attack, heart failure, pneumonia, chronic obstructive pulmonary disease, elective hip or knee replacement, or coronary artery bypass graft surgery. 11 The list is likely to expand, and epilepsy would be a reasonable first neurologic disease to include, given its multiple treatment choices, and the clear association between outpatient epilepsy care quality and health outcomes across epilepsy subtypes.
Readmitted persons with seizure in our study had more medical comorbidities and were more likely to be discharged to another health care facility on their index admission than patients who were not readmitted. Of the comorbid conditions we could measure, several may predispose to seizure, provoke seizure in a susceptible individual, or be treated with a medication that can lower seizure threshold, including diabetes, metastatic cancer, renal failure, fluid and electrolyte disorders, and psychosis. Comorbid brain tumors, hemorrhagic stroke, and alcohol abuse were associated with readmission. This is consistent with the known increased risk of seizure in these chronic conditions. 12,13 Subarachnoid hemorrhage and traumatic brain injury were interestingly not associated with readmission and this may reflect the static or slowly progressive nature of these diseases.
Participants with public insurance (Medicare or Medicaid) were associated with higher readmission rates as compared to participants with private insurance in this study. This may reflect unmeasured differences in comorbidity burden (for example, one automatically qualifies for Medicaid with certain disability diagnoses); it may also reflect differences in postdischarge care resources, which may be more robustly provided by private insurers. In addition, the oldest age group (>85) was associated with a decreased likelihood of readmission; this may be due to increased (and unmeasurable) out of hospital mortality in this group, or may reflect an effort to avoid hospitalization in this group, perhaps as part of end of life care.
Remarkably, status epilepticus and altered mental status, diagnoses that one might predict would correlate with the severity of the seizure, were not significantly associated with readmission. Altered mental status and status epilepticus in our population may frequently be due to reversible, identifiable triggers in a sensitive population (persons with epilepsy). Although we used validated ICD-9 codes to identify adults with seizure, there is less certainty about the specificity of the ICD-9 code for status epilepticus, which could be used as a billing code for evaluation purposes (to justify long-term EEG monitoring or MRI). Patient safety and quality-driven hospital processes may support prompt or accurate identification (and treatment) of status epilepticus, subclinical status epilepticus, and altered mental status, thus reducing the potential for long-term injury. Future studies may better define which hospital structure and processes most strongly associate with favorable hospital outcomes.
Importantly, the most common reason for readmission was epilepsy/convulsion. This suggests that there is an opportunity for improvement as patients are not being readmitted for unforeseeable complications. Although documented adverse events were uncommon, readmitted patients were more likely to have had an adverse event during their index admission. The association with adverse medical events should be further investigated in a study with more granular, patient level data to better understand the health care structure (e.g., neurology intensive care unit, continuous EEG, neurology nursing) and processes (hospital protocols for neurologist consultations, long-term monitoring) associated with the presence (and absence) of adverse events. In addition, outpatient data are not available in this dataset, so one cannot examine the relationship between outpatient follow-up and readmission. 
Primary insurance
This study has limitations associated with administrative claims data, which contain codes produced for billing and documentation purposes. As discussed above, additional studies with richer clinical information, such as electronic medical records, will be helpful for understanding which health care structures and processes enable or prevent readmission. In addition, we are methodologically limited by the structure of the NRD, which does not allow us to track admission from one year to the next, and thus we were forced to censor some admissions due to inadequate follow-up. In addition, we chose to use both validated epilepsy codes, although these have been validated in different administrative databases, not the NRD. We also used unvalidated convulsion codes, which are less specific for epilepsy but are more likely to reflect real-world conditions-capturing patients who would be admitted and cared for as though they had had a seizure. In addition, we used robustly validated codes for associated conditions and complications when available, but some diagnoses, such as those for substance use, have been less thoroughly studied. Finally, our data are from 2014; future studies of secular trends in readmissions are needed to provide historical context and understand the extent to which outcomes can (or have) improve(d). In spite of these limitations, we present national data on shortterm hospitalization outcomes of emergent admissions of adults for seizure in the United States. Further investigation into understanding preventable drivers of readmission in this population presents an opportunity to improve patient care.
